rood blauwe elepsis logo Belegger.nl

ASMI resultaten Q2 2011

10 Posts
| Omlaag ↓
  1. florida7 28 juli 2011 00:10
    ASM INTERNATIONAL N.V. REPORT SECOND QUARTER 2011 OPERATING RESULTS

    ALMERE, The Netherlands - July 27, 2011 - ASM International N.V. (NASDAQ: ASMI and Euronext Amsterdam: ASM) reports today its second quarter 2011 operating results in accordance with US GAAP.



    Highlights:



    Net sales for the second quarter 2011 were EUR 474 million, up 10% quarter-to-quarter and up 57% year on year. Excluding the acquired SEAS business, net sales increased by 9% quarter-to -quarter. Net sales of our Front-end segment were up 5% quarter-to-quarter while comparable Back-end sales increased by 11%.

    Result from operations increased from EUR 94 million in Q1 2011 to EUR 104 million in Q2 2011. The second quarter of 2010 showed a profit of EUR 80 million;

    The Front-end segment increased its operating profit from EUR 18.7 million to EUR 20.8 million quarter-to-quarter. Q2 2010 showed an operating profit of EUR 3.6 million (including EUR 3.3 million restructuring charges);

    The Back-end segment operating profit increased from EUR 75.0 million to EUR 83.2 million quarter-to-quarter. The second quarter of 2010 showed an operating profit of  EUR 76.6 million.



    Second quarter 2011 net earnings were EUR 50 million compared to net earnings of EUR 40 million for the first quarter of 2011 and EUR 48 million for the second quarter of 2010. Net earnings of both previous quarter and the second quarter last year included effects of the revaluation of the conversion option. Excluding this revaluation net earnings were EUR 45 million for the previous quarter and EUR 34 million for the second quarter of 2010.

    Book to bill in the second quarter was 0.7, both in the Front-end and the Back-end segment. The Backlog decreased from Euro 579 million at the end of the first quarter to EUR 436 million at the end of the second quarter.


    Comment

    Commenting on the results, Chuck del Prado, President and Chief Executive Officer of ASM International, said, "The second quarter sales came in at a record level. As well in the Front-end as in the Back-end we recorded an all-time high sales level, leading to an EPS of EUR 0.84. The quarter showed again a strong performance of the newly acquired AS business".



    Outlook

    The current market uncertainty leads to a situation whereby our customers are taking more time to assess their overall capacity plans. This has led in Q2 as compared to Q1 to a lower order intake for our Back-end and Front-end operations. We do not expect that this situation will improve in the 3rd quarter. Taking our current backlog into account, we expect that this will lead to a sales decrease in Q3, both for our Back-end and Front-end operations.





    About ASM International

    ASM International N.V., headquartered in Almere, the Netherlands, and its subsidiaries design and manufacture equipment and materials used to produce semiconductor devices. ASM International and its subsidiaries provide production solutions for wafer processing (Front-end segment) as well as assembly and packaging (Back-end segment) through facilities in the United States, Europe, Japan and Asia. ASM International's common stock trades on NASDAQ (symbol ASMI) and the Euronext Amsterdam Stock Exchange (symbol ASM). For more information, visit ASMI's website at www.asm.com.





    Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: All matters discussed in this statement, except for any historical data, are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These include, but are not limited to, economic conditions and trends in the semiconductor industry generally and the timing of the industry cycles specifically, currency fluctuations, corporate transactions, financing and liquidity matters, the success of restructurings, the timing of significant orders, market acceptance of new products, competitive factors, litigation involving intellectual property, shareholder and other issues, commercial and economic disruption due to natural disasters, terrorist activity, armed conflict or political instability, epidemics and other risks indicated in the Company's filings from time to time with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's reports on Form 20-F and Form 6-K. The Company assumes no obligation nor intends to update or revise any forward-looking statements to reflect future developments or circumstances.



    ASM International will host an investor conference call and web cast on Thursday, July 28, 2011 at 15:00 Continental European Time (9:00 a.m. - US Eastern Time, 9:00 p.m. Hong Kong Time). The teleconference dial-in numbers are as follows:

    United States: +1 718 223 2330
    International: + 44 (0)20 7138 0813
    Access code: 8345171
    A simultaneous audio web cast will be accessible at www.asm.com.Â

    The teleconference will be available for replay, beginning one hour after completion of the live broadcast, through August 27, 2011.

    The replay dial-in numbers are:

    United States: +1 347 366 9565
    International: + 44 (0)20 7111 1244
    Access Code: 8345171#
    Investor Relations:

    Erik Kamerbeek

    +31 88 100 8500

    Erik.Kamerbeek@asm.com



    Mary Jo Dieckhaus

    +1 212 986 2900

    MaryJo.Dieckhaus@asm.com




    Media Contacts:

    Ian Bickerton

    +31 20 6855 955

    +31 62501 8512


    ASMI Q2 2011 Operating Results

    --------------------------------------------------------------------------------

    This press release was issued by ASM International N.V.

    To alter your subscription profile or to unsubscribe, please go to: www.asm.com/newsroom

    ASM International N.V. Investor Relations

  2. [verwijderd] 28 juli 2011 00:57
    De resultaten over kwartaal 2 zijn natuurlijk uitmuntend. Opvallend is het goede resultaat in front end. Netto winst over dit jaar is al 90 miljoen. Ook al verzwakt de order porto, dan is een winst van 150 a 160 miljoen over dit jaar haalbaar, dus 3 euro per aandeel. Bij 10 maal de winst moet een koers van 30 euro haalbaar zijn. We zullen zien hoe de koers zich ontwikkelt.
  3. [verwijderd] 28 juli 2011 07:36
    Ondanks de heftige reactie in Hong Kong (wellicht ook algemeen sentiment) nog altijd een discount van meer dan 8 Euro; de reden voor de discount kan nu echter niet meer de front end zijn.
  4. [verwijderd] 29 juli 2011 13:18
    Nou ASMI staat alweer onder de 20, ik heb het gekocht omdat ik dacht dat het wel weer boven de 30 kon komen, kan nu nog wel even duren vermoed ik.
10 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.017
AB InBev 2 5.496
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.658
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 265
Accsys Technologies 23 10.654
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 189
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.752
Aedifica 3 916
Aegon 3.258 322.841
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.893
Agfa-Gevaert 14 2.050
Ahold 3.538 74.336
Air France - KLM 1.025 35.043
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.040
Alfen 16 24.848
Allfunds Group 4 1.473
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.222
AMG 971 133.345
AMS 3 73
Amsterdam Commodities 305 6.690
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.999
Apollo Alternative Assets 1 17
Apple 5 382
Arcadis 252 8.776
Arcelor Mittal 2.033 320.709
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.302
Aroundtown SA 1 219
Arrowhead Research 5 9.739
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.103
ASML 1.766 107.286
ASR Nederland 21 4.486
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.673
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392